Lu et al. [58] found that SMOC2 expression was increased in sphere cultures and in CD133/CD44-positive cells compared with CD133/CD44-negative cells and also boosted the chemoresistance of endometrial cancer cells. This evidence concerns the gene PROM1 and endometrial cancer.